Post-Marketing Surveillance of TISSUCOL for Hemostasis in Subjects Undergoing Vascular Reconstruction With Polytetrafluoroethylene (PTFE) Prosthesis

NCT00163592 · clinicaltrials.gov ↗

COMPLETED

Status

60

Enrollment

INDUSTRY

Sponsor class

Conditions

Femoral Vascular Anastomosis

Interventions

DRUG: Tissucol®
PROCEDURE: Control: Conventional treatment, i.e. compression with swabs

Sponsor

Baxter Healthcare Corporation